RNA methyltransferase NSUN5 promotes oral squamous cell carcinoma proliferation and migration by enhancing YAP1

Huiqi Bao1, Jun Yuan2, Baixue Zhai2

  • 1Department of Stomatology, Songjiang Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 201600, China.

Odontology
|August 13, 2026
PubMed

Insights

NSUN5, a key methyltransferase, is upregulated in oral squamous cell carcinoma (OSCC) and promotes tumor progression by stabilizing YAP1 mRNA. This identifies a novel NSUN5/YAP1 pathway in OSCC development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Epigenetics

Background:

  • m5C modifications are crucial in oral squamous cell carcinoma (OSCC) development.
  • NSUN5, a methyltransferase, catalyzes mRNA m5C modification, but its role in OSCC is unknown.

Purpose of the Study:

  • To investigate the oncogenic role and molecular mechanisms of NSUN5 in OSCC progression.
  • To explore the NSUN5/YAP1 pathway in OSCC.

Main Methods:

  • Analysis of NSUN5 expression in 34 OSCC tissues and 7 cell lines using qRT-PCR, Western blotting, and IHC.
  • Evaluation of NSUN5's impact on OSCC cell proliferation, migration, and invasion via CCK8, colony formation, and wound healing assays.
  • Detection of YAP1 expression and m5C modification in NSUN5-silenced cells.

Main Results:

  • NSUN5 was upregulated in OSCC tissues and correlated with poor prognosis.
  • NSUN5 promoted OSCC cell proliferation, migration, invasion, and tumor growth in vivo.
  • NSUN5 stabilizes YAP1 mRNA via m5C modification, increasing YAP1 expression.

Conclusions:

  • NSUN5 acts as an oncogene in OSCC progression.
  • The NSUN5/YAP1 axis is a novel pathway regulating YAP1 expression in OSCC.
  • Targeting NSUN5 may offer a therapeutic strategy for OSCC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mismatch Repair01:20

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
Mismatch Repair01:36

Mismatch Repair

Overview